Skip to content

Medicine Man Technologies, Inc.: 10-Q filed 2021-11-15

What Medicine Man Technologies, Inc. reported in its quarterly report filed 2021-11-15 (fiscal Q3 2021): 48 published measures, 134 facts as tagged in accession 0001683168-21-005695.

This filing

Form
10-Q (quarterly report)
Filed
2021-11-15
Fiscal period
fiscal Q3 2021
Accession
0001683168-21-005695 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All Medicine Man Technologies, Inc. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2021-09-30194,731,295USD
At 2020-12-3170,682,601USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2021-09-3076,998,200USD
At 2020-12-3128,907,742USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2021-09-30117,733,095USD
At 2021-06-30111,939,679USD
At 2020-12-3141,774,859USD
At 2020-09-3025,718,333USD
At 2020-06-3027,511,058USD
At 2019-12-3126,579,945USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2021-09-3021,168,816USD
At 2020-12-311,231,235USD
At 2020-09-302,981,688USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2021-07-01 to 2021-09-30968,756USD92
2021-01-01 to 2021-09-301,689,289USD273
2020-07-01 to 2020-09-30-2,914,211USD92
2020-01-01 to 2020-09-30-10,889,228USD274

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2021-01-01 to 2021-09-304,814,104USD273
2020-01-01 to 2020-09-30-6,303,992USD274

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2021-01-01 to 2021-09-303,869,658USD273
2020-01-01 to 2020-09-30976,685USD274

Contract revenue excluding tax

Revenue from customer contracts excluding assessed taxes under this specific taxonomy concept. It is not automatically comparable to older revenue tags.

PeriodValueUnitDays
2021-07-01 to 2021-09-3031,835,305USD92
2021-01-01 to 2021-09-3081,904,261USD273
2020-07-01 to 2020-09-307,430,374USD92
2020-01-01 to 2020-09-3016,057,837USD274

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2021-01-01 to 2021-09-3090,761,874USD273
2020-01-01 to 2020-09-3042,000USD274

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2021-01-01 to 2021-09-30-75,644,398USD273
2020-01-01 to 2020-09-30-3,107,900USD274

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2021-09-30-46,188,829USD
At 2020-12-31-42,293,098USD

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2021-07-01 to 2021-09-3056,139,416shares92
2021-01-01 to 2021-09-3056,688,640shares273
2020-07-01 to 2020-09-3041,568,147shares92
2020-01-01 to 2020-09-3041,242,041shares274

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2021-07-01 to 2021-09-300.02USD/shares92
2021-01-01 to 2021-09-300.03USD/shares273
2020-07-01 to 2020-09-30-0.07USD/shares92
2020-01-01 to 2020-09-30-0.26USD/shares274

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2021-07-01 to 2021-09-301,312,817USD92
2021-01-01 to 2021-09-301,997,905USD273
2020-07-01 to 2020-09-300USD92
2020-01-01 to 2020-09-300USD274

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2021-09-308,805,348USD
At 2020-12-312,584,798USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2021-07-01 to 2021-09-301,228,764USD92
2021-01-01 to 2021-09-303,865,588USD273
2020-07-01 to 2020-09-301,453,986USD92
2020-01-01 to 2020-09-305,815,808USD274

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2021-07-01 to 2021-09-303,837,000USD92
2021-01-01 to 2021-09-306,793,010USD273
2020-07-01 to 2020-09-30-3,618,826USD92
2020-01-01 to 2020-09-30-14,079,861USD274

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2021-09-3037,956,752USD
At 2020-12-315,997,365USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2021-09-3013,944,557USD
At 2020-12-3112,360,386USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2021-09-30953,467USD
At 2020-12-313,508,478USD

Goodwill carrying amount

Recognized goodwill remaining after accumulated impairment. It arises from business combinations and does not measure the current value of the company’s brand.

PeriodValueUnitDays
At 2021-09-3042,090,944USD
At 2020-12-3153,046,729USD

Net finite-lived intangible assets

Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.

PeriodValueUnitDays
At 2021-09-3098,072,970USD
At 2020-12-313,082,044USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2021-09-303,530,520USD
At 2020-12-311,270,380USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2021-07-01 to 2021-09-3011,218,992USD92
2021-01-01 to 2021-09-3030,418,486USD273
2020-07-01 to 2020-09-306,400,290USD92
2020-01-01 to 2020-09-3020,233,567USD274

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2021-09-3010,678,381USD
At 2020-12-312,619,145USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2021-07-01 to 2021-09-3015,055,992USD92
2021-01-01 to 2021-09-3037,211,496USD273
2020-07-01 to 2020-09-302,781,464USD92
2020-01-01 to 2020-09-306,153,706USD274

Cost of revenue

Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.

PeriodValueUnitDays
2021-07-01 to 2021-09-3016,779,313USD92
2021-01-01 to 2021-09-3044,692,765USD273
2020-07-01 to 2020-09-304,648,910USD92
2020-01-01 to 2020-09-309,904,131USD274

Selling, general and administrative expense

Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.

PeriodValueUnitDays
2021-07-01 to 2021-09-305,593,336USD92
2021-01-01 to 2021-09-3013,580,469USD273
2020-07-01 to 2020-09-301,298,693USD92
2020-01-01 to 2020-09-303,054,091USD274

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2021-09-3044,400,853shares
At 2020-12-3142,169,041shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2021-09-30165,393,733USD
At 2020-12-3185,357,835USD

Operating lease right-of-use asset

Carrying amount of the right to use leased assets under operating leases. It reflects discounted remaining payments, not the value of the underlying property.

PeriodValueUnitDays
At 2021-09-303,626,617USD
At 2020-12-312,579,036USD

Operating lease liability

Present value of remaining operating lease payments. Discount-rate choices and lease terms affect the amount; it is not the sum of undiscounted future rent.

PeriodValueUnitDays
At 2021-09-304,158,486USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

PeriodValueUnitDays
At 2021-09-3010,436,441USD
At 2020-12-313,457,377USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2021-09-301,631,093USD
At 2020-12-31872,579USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2021-09-30448,062USD
At 2020-12-3151,879USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2021-09-3011,660,237USD
At 2020-12-312,705,445USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2021-09-302,579,035USD
At 2020-12-31614,200USD

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

PeriodValueUnitDays
2021-07-01 to 2021-09-302,281,573USD92
2021-01-01 to 2021-09-303,687,194USD273
2020-07-01 to 2020-09-30-2,914,211USD92
2020-01-01 to 2020-09-30-10,889,228USD274

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

PeriodValueUnitDays
2021-07-01 to 2021-09-30968,756USD92
2021-01-01 to 2021-09-301,689,289USD273
2020-07-01 to 2020-09-30-2,914,211USD92
2020-01-01 to 2020-09-30-10,889,228USD274

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2021-07-01 to 2021-09-30364,399USD92
2021-01-01 to 2021-09-30818,174USD273
2020-07-01 to 2020-09-30226,358USD92
2020-01-01 to 2020-09-30317,332USD274

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

PeriodValueUnitDays
2021-01-01 to 2021-09-307,779,828USD273
2020-01-01 to 2020-09-30322,292USD274

Amortization of intangible assets

Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.

PeriodValueUnitDays
2021-07-01 to 2021-09-302,608,282USD92
2021-01-01 to 2021-09-306,961,654USD273
2020-07-01 to 2020-09-301,665USD92
2020-01-01 to 2020-09-304,960USD274

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

PeriodValueUnitDays
2021-07-01 to 2021-09-300USD92
2021-01-01 to 2021-09-300USD273
2020-07-01 to 2020-09-300USD92
2020-01-01 to 2020-09-3032,621USD274

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2021-07-01 to 2021-09-30-1,555,427USD92
2021-01-01 to 2021-09-30-3,105,816USD273
2020-07-01 to 2020-09-30704,615USD92
2020-01-01 to 2020-09-303,190,633USD274

Interest paid, net

Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.

PeriodValueUnitDays
2021-01-01 to 2021-09-303,862,970USD273
2020-01-01 to 2020-09-300USD274

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2021-01-01 to 2021-09-3050,282,797USD273
2020-01-01 to 2020-09-3042,000USD274

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2021-01-01 to 2021-09-302,179,646USD273
2020-01-01 to 2020-09-30-1,292,509USD274

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2021-01-01 to 2021-09-303,034,246USD273
2020-01-01 to 2020-09-30-271,305USD274

Inspect the source

Entity
Medicine Man Technologies, Inc. / CIK 0001622879
Captured
SEC response SHA-256
1261bd7a9caa81b103d72d0d0ab2acc4054c1fb2aa448834ecbc9bb252b5bd72

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001622879.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))